Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.

This study has been completed.
Sponsor:
Collaborator:
Hoechst Marion Roussel
Information provided by:
NIH AIDS Clinical Trials Information Service
ClinicalTrials.gov Identifier:
NCT00002192
First received: November 2, 1999
Last updated: June 23, 2005
Last verified: August 1997
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given